Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial

Alex F. Herrera, Lu Chen, Yago Nieto, Leona Holmberg, Patrick Johnston, Matthew Mei, Leslie Popplewell, Saro Armenian, Thai Cao, Leonardo Farol, Firoozeh Sahebi, Ricardo Spielberger, Robert Chen, Auayporn Nademanee, Sandrine Puverel, Mary Nwangwu, Peter Lee, Joo Song, Alan Skarbnik, Neena KennedyLacolle Peters, Steven T. Rosen, Larry W. Kwak, Stephen J. Forman, Tatyana Feldman

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences